Wealth Quarterback’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Sell
1,356
-273
-17% -$277K 0.49% 41
2025
Q4
$1.75M Sell
1,629
-120
-7% -$115K 0.63% 30
2025
Q3
$1.33M Buy
1,749
+325
+23% +$242K 0.52% 41
2025
Q2
$1.11M Buy
1,424
+251
+21% +$195K 0.53% 42
2025
Q1
$969K Buy
1,173
+62
+6% +$51.6K 0.55% 45
2024
Q4
$857K Sell
1,111
-606
-35% -$502K 0.4% 49
2024
Q3
$1.52M Buy
1,717
+802
+88% +$721K 0.79% 26
2024
Q2
$828K Sell
915
-485
-35% -$388K 0.47% 43
2024
Q1
$1.09M Buy
1,400
+126
+10% +$89.7K 0.61% 32
2023
Q4
$743K Buy
1,274
+6
+0.5% +$3.5K 0.45% 50
2023
Q3
$681K Sell
1,268
-27
-2% -$13.9K 0.59% 42
2023
Q2
$607K Sell
1,295
-64
-5% -$26.8K 0.42% 47
2023
Q1
$467K Buy
1,359
+36
+3% +$12.1K 0.4% 59
2022
Q4
$484K Sell
1,323
-42
-3% -$14.9K 0.4% 57
2022
Q3
$441K Buy
1,365
+19
+1% +$6.02K 0.47% 53
2022
Q2
$437K Buy
+1,346
New +$404K 0.34% 68
2021
Q3
$329K Sell
1,424
-48
-3% -$11.8K 0.22% 81
2021
Q2
$338K Buy
+1,472
New +$296K 0.21% 82
2020
Q4
$240K Buy
1,419
+89
+7% +$13.3K 0.2% 95
2020
Q3
$218K Hold
1,330
0.2% 104
2020
Q2
$218K Buy
1,330
+999
+302% +$153K 0.2% 104
2020
Q1
$45.9K Sell
331
-2,450
-88% -$337K 0.04% 240
2019
Q4
$76.6K Buy
+2,781
New +$322K 0.07% 190

Other funds holding LLY

Wealth Quarterback's LLY Position: Q1 2026 in Review

Wealth Quarterback reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $277K and leaving 1,356 shares worth $1.25M. The position accounts for 0.49% of the portfolio, ranked #41.

Wealth Quarterback first reported a position in LLY in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.75M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wealth Quarterback held 1,356 shares of Eli Lilly worth $1.25M as of Q1 2026.
  • Wealth Quarterback sold 273 Eli Lilly shares in Q1 2026, an estimated $277K.
  • Eli Lilly made up 0.49% of Wealth Quarterback's portfolio in Q1 2026, its #41 holding.
  • Wealth Quarterback first reported a position in Eli Lilly in Q4 2019 and has held it in 23 quarters since.
  • Wealth Quarterback's Eli Lilly position peaked at $1.75M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wealth Quarterback's 13F filing for Q1 2026, filed 9 Apr 2026.